| A history of the criminal law of England JF Stephen Cambridge University Press, 2014 | 2870 | 2014 |
| Vedolizumab as induction and maintenance therapy for Crohn's disease WJ Sandborn, BG Feagan, P Rutgeerts, S Hanauer, JF Colombel, ... New England Journal of Medicine 369 (8), 711-721, 2013 | 2471 | 2013 |
| Ammonia-oxidizing bacteria: a model for molecular microbial ecology GA Kowalchuk, JR Stephen Annual Reviews in Microbiology 55 (1), 485-529, 2001 | 1675 | 2001 |
| On energy harvesting from ambient vibration NG Stephen Journal of sound and vibration 293 (1-2), 409-425, 2006 | 1141 | 2006 |
| Physics of liquid crystals MJ Stephen, JP Straley Reviews of Modern Physics 46 (4), 617, 1974 | 1128 | 1974 |
| Enhanced photocatalytic activity of ZnO/CuO nanocomposite for the degradation of textile dye on visible light illumination R Saravanan, S Karthikeyan, VK Gupta, G Sekaran, V Narayanan, ... Materials Science and Engineering: C 33 (1), 91-98, 2013 | 1104 | 2013 |
| Dragging ras back in the ring AG Stephen, D Esposito, RK Bagni, F McCormick Cancer cell 25 (3), 272-281, 2014 | 971 | 2014 |
| The English Utilitarians L Stephen Cambridge University Press, 2011 | 581 | 2011 |
| Stephen Machin.“ E Berman, J Bound Implications of Skill, 1998 | 554 | 1998 |
| First‐Order Dispersion Forces MJ Stephen The Journal of Chemical Physics 40 (3), 669-673, 1964 | 457 | 1964 |
| Vedolizumab Maintenance Therapy for Crohn's Disease: Results of GEMINI II, a Randomized, Placebo-Controlled, Double-Blind, Multi-center Phase 3 Trial: 1542 S Hanauer, JF Colombel, B Feagan, P Rutgeerts, W Sandborn, B Sands, ... Official journal of the American College of Gastroenterology| ACG 107, S620-S621, 2012 | 8 | 2012 |
| Risk Assessment and Minimization for Progressive Multifocal Leukoencephalopathy (PML RAMP): A Program to Assess for Potential Early Signs and Symptoms of PML during Clinical … D Clifford, M McAuliffe, K Stephens, E Major, I Fox, C Milch, S Sankoh, ... Official journal of the American College of Gastroenterology| ACG 108, S502, 2013 | 7 | 2013 |
| Vedolizumab Induction Therapy for Crohn's Disease: Results of Gemini II, a Randomized, Placebo-Controlled, Double-Blind, Multicenter Phase 3 Trial: 1550 W Sandborn, B Sands, JF Colombel, B Feagan, S Hanauer, P Rutgeerts, ... Official journal of the American College of Gastroenterology| ACG 107, S624-S625, 2012 | 5 | 2012 |
| A programme for risk assessment and minimisation of progressive multifocal leukoencephalopathy developed for vedolizumab clinical trials A Parikh, K Stephens, E Major, I Fox, C Milch, S Sankoh, MH Lev, ... Drug Safety 41, 807-816, 2018 | 4 | 2018 |
